Protective Autophagy Attenuates the Cytotoxicity of MTI-31 in Renal Cancer Cells by Activating the ERK Pathway
Applied Biochemistry and Biotechnology · 2024
DOI: 10.1007/s12010-023-04569-9 ↗Kurz gefasst
Fachartikel in der Zeitschrift Applied Biochemistry and Biotechnology, 2024. Verfasst von Yiwen Zang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Huashan Hospital, Fudan University, 12 Middle Urumqi Road, Shanghai, 200040, China. Hauptthemen laut MEDLINE: Autophagy, Kidney Neoplasms, MAP Kinase Signaling System, Carcinoma, Renal Cell. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 29 Literaturangaben.
Abstract (Originalsprache)
The mammalian target of rapamycin (mTOR) is a key regulatory molecular target to treat cancer, and MTI-31 is a potent mTOR inhibitory agent for the therapeutically target of the renal cell carcinoma (RCC). However, the therapeutic efficacy of MTI-31 is limited by multiple factors, including autophagy. MTI-31 can activate cells to generate autophagy, which may in turn indirectly affect cell proliferation and apoptosis. We aimed to observe changes in cell protective autophagy via the ERK pathway and explore the potential mechanism underlying drug resistance of RCC cells to MTI-31. Different concentrations of 786-O and RCC4 cells were co-cultured with MTI-31 for distinct durations. The result of autophagy marker detection by Western blot showed that MTI-31 could induce RCC cells to produce autophagy in a dose and time-dependent manner. After treating the RCC cells with the autophagy inhibitor chloroquine (CQ), CCK8 and Western blot assays demonstrated that CQ could effectively enhance cell apoptosis induced by MTI-31 and that the autophagy induced by MTI-31 was cytoprotective. In addition, CCK8 and Western blot demonstrated that MTI-31 exerted its effect by activating the ERK pathway rather than the JNK or p38 pathway. The use of the ERK inhibitor AZD6244 to block the ERK pathway could effectively promote cell apoptosis induced by MTI-31. AZD6244 attenuated the autophagy induced by MTI-31 and increased the cytotoxicity of MTI-31. Western blot also demonstrated that MTI-31-induced autophagy was mediated by the downstream regulators of ERK pathways, including Beclin-1 and Bcl-2. It demonstrated that the MTI-31 mediated activation ERK pathway is associated with the induction of autophagy, and autophagy can attenuate the cytotoxicity of MTI-31 on RCC cells. In summary, inhibition of ERK pathway-mediated autophagy can rectify drug resistance to MTI-31 effectively.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Huashan Hospital, Fudan University, 12 Middle Urumqi Road, Shanghai, 200040, China.
- Institute of Urology, Fudan University, Shanghai, 200040, China.
- Department of Geriatrics, Huashan Hospital, Fudan University, Shanghai, 200040, China.
- Teaching Center of Experimental Medicine, Shanghai Medical College, Fudan University, 138 Yixueyuan Rd, Shanghai, 200032, China. fdshmuwh@fudan.edu.cn.
- Huashan Hospital, Fudan University, 12 Middle Urumqi Road, Shanghai, 200040, China. zuquanxiong2021@126.com.
- Institute of Urology, Fudan University, Shanghai, 200040, China. zuquanxiong2021@126.com.
Zitieren
APA
Zang, Y., Yang, C., Dai, M. S., Zhang, W., Zou, L., Hu, J., Hu, Y., Xu, C., Liu, R., Wang, H., & Xiong, Z. (2024). Protective Autophagy Attenuates the Cytotoxicity of MTI-31 in Renal Cancer Cells by Activating the ERK Pathway. Applied Biochemistry and Biotechnology. https://doi.org/10.1007/s12010-023-04569-9
Vancouver
Zang Y, Yang C, Dai MS, Zhang W, Zou L, Hu J, et al. Protective Autophagy Attenuates the Cytotoxicity of MTI-31 in Renal Cancer Cells by Activating the ERK Pathway. Applied Biochemistry and Biotechnology. 2024. doi:10.1007/s12010-023-04569-9
BibTeX
@article{Zang2024,
author = {Zang, Yiwen and Yang, Chen and Dai, Meng-Shi and Zhang, Wenye and Zou, Lujia and Hu, Jimeng and Hu, Yun and Xu, Chenyang and Liu, Rongzong and Wang, Hao and Xiong, Zuquan},
title = {Protective Autophagy Attenuates the Cytotoxicity of MTI-31 in Renal Cancer Cells by Activating the ERK Pathway},
journal = {Applied Biochemistry and Biotechnology},
year = {2024},
doi = {10.1007/s12010-023-04569-9}
}
EUVIMED